Vaccines & Antibodies
Against Resistant Infections
Latest News
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections
Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help curb the rising threat of drug resistant bacteria
VAXDYN IS A MEMBER OF THE BEAM ALLIANCE
Vaxdyn in member of the BEAM Alliance. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong Network
VAXDYN EN EL BOLETÍN MENSUAL DE ASEBIO
El proyecto ACINETOCLINIC, financiado por la convocatoria RETOS-COLABORACIÓN 2016, se incluye en el boletin de noticias de las sociedad